BACOBA AG
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Private
- Established
- 2013-01-01
- Employees
- -
- Market Cap
- -
Safety, Tolerability, and Pharmacokinetics of BAP5191 in Healthy Adults Following Topical Application of Repeat Doses
- First Posted Date
- 2023-05-08
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Bacoba AG
- Target Recruit Count
- 24
- Registration Number
- NCT05848453
- Locations
- 🇨ðŸ‡
Universität Basel Departement Klinische Forschung Ambulantes Studienzentrum, Basel, Switzerland
© Copyright 2025. All Rights Reserved by MedPath